Connor Clark & Lunn Investment Management Ltd. Has $353,000 Position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)
Connor Clark & Lunn Investment Management Ltd. decreased its stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX...
Your Source for Insightful Trends and Discussions.
Connor Clark & Lunn Investment Management Ltd. decreased its stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX...
Cibc World Markets Corp bought a new stake in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX...
Natixis Advisors LLC increased its position in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free...
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) CEO Richard Scott Struthers sold 17,338 shares...